2025 Japan Apheresis Market Revenue Opportunities Report
Description
The 2025 Japan Apheresis Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Apheresis Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the apheresis market in Japan are Asahi Kasei Medical Co., Ltd., Terumo Corporation, Nikkiso Co., Ltd., and Kawasumi Laboratories Inc. Asahi Kasei Medical, based in Tokyo, offers a wide range of products including therapeutic apheresis devices and filters, bolstered by its acquisition of Virusure in 2019 to strengthen bioprocess solutions. Terumo Corporation is a global leader in blood component and therapeutic apheresis technologies and has expanded collaborations in related treatments. Nikkiso, with a strong presence in dialysis and blood purification, began launching new apheresis products in Japan from 2020, leveraging its advanced industrial technology. Kawasumi Laboratories is notable for developing advanced medical technologies including AI-assisted systems for apheresis monitoring.
These companies contribute significantly to Japan's growing apheresis market, which reached $142.6 million in 2024 and is forecasted to grow at a CAGR of 6.08% through 2033. They are driving innovations through technological advancements, strategic partnerships, and expansions to meet the rising demand for therapeutic and plasma apheresis procedures. The market growth is supported by increased incidence of chronic diseases, enhanced healthcare infrastructure, and rising awareness of apheresis benefits among clinicians and patients. Their extensive product portfolios include dialyzers, therapeutic apheresis systems, and blood component collection devices, addressing a broad range of clinical indications and blood processing needs domestically and abroad.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Apheresis Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the apheresis market in Japan are Asahi Kasei Medical Co., Ltd., Terumo Corporation, Nikkiso Co., Ltd., and Kawasumi Laboratories Inc. Asahi Kasei Medical, based in Tokyo, offers a wide range of products including therapeutic apheresis devices and filters, bolstered by its acquisition of Virusure in 2019 to strengthen bioprocess solutions. Terumo Corporation is a global leader in blood component and therapeutic apheresis technologies and has expanded collaborations in related treatments. Nikkiso, with a strong presence in dialysis and blood purification, began launching new apheresis products in Japan from 2020, leveraging its advanced industrial technology. Kawasumi Laboratories is notable for developing advanced medical technologies including AI-assisted systems for apheresis monitoring.
These companies contribute significantly to Japan's growing apheresis market, which reached $142.6 million in 2024 and is forecasted to grow at a CAGR of 6.08% through 2033. They are driving innovations through technological advancements, strategic partnerships, and expansions to meet the rising demand for therapeutic and plasma apheresis procedures. The market growth is supported by increased incidence of chronic diseases, enhanced healthcare infrastructure, and rising awareness of apheresis benefits among clinicians and patients. Their extensive product portfolios include dialyzers, therapeutic apheresis systems, and blood component collection devices, addressing a broad range of clinical indications and blood processing needs domestically and abroad.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
